Epilepsy from hypoplastic left brain is generally not curable, but can be managed with aggressive and effective treatment.
Epilepsy caused by dysplasia is generally difficult to cure, and most children develop the disease at a young age, requiring long-term treatment with antiepileptic drugs, such as traditional antiepileptic drugs, including phenytoin sodium and carbamazepine, and newer antiepileptic drugs, including topiramate and lamotrigine, among others.
Most epilepsies induced by cerebral dysplasia are generally drug-refractory epilepsies, which can cause progressive neuropsychiatric dysfunction, or degeneration, once the seizures are prolonged.
In addition, encephalopathies, regardless of the type of epilepsy, are harmful and should be treated early.